This guideline is intended to provide recommendations to applicants wishing to submit an application for a licence to act as a wholesaler of medicine and/or scheduled substances. It is not intended as an exclusive approach and should not be taken as a complete or authoritative statement...
This document is intended to provide guidance on the implementation of renewals for medicine registration. This will be a “living document” and will be updated as required. Download: Annexure 1: Renewals Process Flow Diagram...
To develop a medicine information data bank on the quality of medicines in circulation and disseminate such information to stakeholders involved in the medicines supply chain. To promote communication and cooperation between stakeholders and partners involved in the medicines supply chain. To identify possible causes of inferior...
This document has been prepared to serve as a guidance document regarding SAHPRA requirements for release of import health products at Ports of Entry - Regulatory Compliance Unit....
This document has been prepared to serve as a guidance document regarding SAHPRA requirements for advertisement of medicines and health products- Regulatory Compliance Unit....
This guideline intends to assist applicants in differentiating between various types of permits, the requirements
for each permit and the relevant fees applicable.
This guideline is applicable to Section 22A permits and related authorizations in Regulatory Compliance. The
scope includes the application process, fee applicable and...
This document has been prepared to serve as a recommendation to applicants regarding the recalls and withdrawal of medicines, and the South African Health Products Regulatory Authority's current thinking on the safety, quality, and efficacy of medicines. SAHPRA reserves the right to request any additional...
This guideline is intended to assist Applicants/ HCRs in the reporting of ADRs/AEFIs associated with the use of health products, as provided for in the scope, and in the management of safety data which may arise during post-registration, including during Phase 4 post-marketing clinical trials....
This document is intended to provide guidance to applicants for lot release requirements for all human vaccines. This will be a “living document” and will be updated on a regular basis. It is important that applicants adhere to the prescribed requirements in order to avoid...
This document is intended to provide guidance to applicants on the scheduling of substances submitted for registration as medicines. It represents the South African Health Products Regulatory Authority’s current thinking on the safety, quality and efficacy of medicines and takes into account the country’s obligations...
